Multiple Sclerosis Cure - Use Of Cheap Low Dose Naltrexone (LDN) Treatment Option Still Not Widespread

Naltrexone is a drug that was initially developed in order to assist drug addicts to kick their drug habit, but was later found to be of significant benefit to sufferers of Multiple Sclerosis (MS) when prescribed in low doses. This has resulted in Low Dose Naltrexone (LDN) becoming an increasingly popular choice for the treatment of MS sufferers in the United States. However, despite LDN being proven to be extremely effective in the treatment of MS, and also being relatively cheap, it is only rarely used in the treatment of MS in the United Kingdom, with a recent survey indicating that only 6% of MS sufferers in the United Kingdom had been advised of the potential benefits of LDN by their General Practitioner (GP).

This survey was conducted by the LDN Research Trust, which is currently conducting its second annual “LDN Aware” Conference in Birmingham, which aims to promote the use of LDN in the treatment of MS and to also secure funding in order carry out further clinical trials on LDN. Linda Elsegood, the founder of the LDN Research Trust, issued the following comment regarding the lack of information as to the potential benefits of LDN in the treatment of MS: “LDN is used widely in the United States to treat MS and a number of other autoimmune diseases. The UK has a lot of catching up to do.”